Clinical Trial Update: Effects of Montelukast on Airway Regulatory T Cells in Asthma [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes ongoing Phase 2 and Phase 3 studies evaluating the effects of montelukast on airway regulatory T cells in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Singulair) (montelukast)

Snippet

Sponsor: Kurume University | Conditions: Asthma | Phase 2, Phase 3 | Status: UNKNOWN